Population-based study of diagnostic assays for Borrelia infection: Comparison of purified flagella antigen assay (Ideia™, Dako Cytomation) and recombinant antigen assay (Liaison®, DiaSorin)

BMC Clinical Pathology

Volumn 8, Issue 1, 2008, Pages

  Petersen, Eskild ^a   Tolstrup, Martin ^a   Capuano, Francesco ^b   Ellermann Eriksen, Svend ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Diasorin SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RECOMBINANT ANTIGEN;

ANTIBODY DETECTION; ARTICLE; BORRELIA INFECTION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FALSE POSITIVE RESULT; FLAGELLUM; GENERAL PRACTICE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; SAMPLE; SEROLOGY;

EID: 43049120041     PISSN: 14726890     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-8-4     Document Type: Article

References (32)

1. Incidence of lyme borreliosis in the Würtzburg region of Germany. HI Huppertz M Bohne SM Standaert H Karch SA Plotkin, Eur J Clin Microbiol Infect Dis 1999 18 697 703 10.1007/s100960050381 10584895
2. Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu latu from patients with neuroborreliosis in Germany. B Wilske U Busch H Eiffert V Fingerle HW Pfister D Rössler V Preac-Mursic, Med Microbiol Immunol 1996 184 195 201 10.1007/BF02456135 8811652
3. Lyme disease. AC Steere, N Engl J Med 2001 345 115 125 10.1056/NEJM200107123450207 11450660
4. Lyme borreliosis. UR Hengge A Tannapfel SK Tyring R Erbel G Arendt T Ruzicka, Lancet Infect Dis 2003 3 489 500 10.1016/S1473-3099(03)00722-9 12901891
5. Diagnosis of lyme borreliosis. ME Aguero-Rosenfeld G Wang I Schwartz GP Wormser, Clin Microbiol Rev 2005 18 484 509 16020686 10.1128/CMR.18.3.484-509. 2005
6. The overdiagnosis of Lyme disease. AC Steere E Taylor GL McHugh EL Logigian, J Am Med Assoc 1993 269 1812 1816 10.1001/jama.269.14.1812 8459513
7. Molecular diagnosis of Lyme disease: review and meta-analysis. JS Dumler, Mol Diagn 2001 6 1 11 11257206
8. Antigenic and genetic heterogeneity of Borrelia borgdorferi populations transmitted by ticks. J Ohnishi J Piesman AM de Silva, Proc Natl Acad Sci USA 2001 98 670 675 11209063 10.1073/pnas.98.2.670
9. Molecular adaptation of Borrelia burgdorferi in the murine host. FT Liang FK Nelson E Fikrig, J Exp Med 2002 196 275 280 12119353 10.1084/jem.20020770
10. An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. FT Liang MB Jacobs LC Bowers MT Phillip, J Exp Med 2002 195 415 422 11854355 10.1084/jem.20011870
11. The European Union concerted action world wide web site for Lyme borreliosis. M Smith G Gettinby M Granstrom JS Gray EC Guy C Revie JN Robertson G Stanek, Zentralbl Bakteriol 1998 287 266 269 9563201
12. Clinical evaluation of guidelines and two-test approach for Lyme disease. AA Blaauw AM van Loon JF Schellekens JWJ Bijlsma, Rheumatol 1999 38 1121 1126 10.1093/rheumatology/38.11.1121
13. The use of local isolates in western blots improves serological diagnosis of Lyme disease in Scotland. S Mavin RM Milner R Evans JMW Chatterton AWL Joss DO Ho-Yen, J Med Microbiol 2007 56 47 51 10.1099/jmm.0.46793-0 17172516
14. Microbiological diagnosis in Lyme borreliosis. B Wilske, Intl J Med Microbiol 2002 291 Suppl 33 114 119 12141735
15. Lyme neuroborreliosis: improvements of the laboratory diagnosis and a survey of epidemiological and clinical features in Denmark 1985-90. K Hansen, Acta Neurol Scand 1994 151 Suppl 1 44
16. Information on Liaison Borrelia IgM and IgG November 15, 2006. DiaSorin
17. Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and a DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis. U Schulte-Spechtel G Lehnert G Liegl V Fingerle C Heimerl BJ Johnson B Wilske, J Clin Microbiol 2003 41 1299 1303 12624072 10.1128/JCM.41.3.1299-1303.2003
18. Bowker's test for symmetry. AH Bowker, J Am Stat Assoc 1948 43 572 574 10.2307/2280710 18123073
19. Statistical Methods in Medical Research. P Armitage, Blackwell Scientific Publications. Oxford 2001
20. An improved recombinant immunoblot for serodiagnosis of Lyme borreliosis. B Wilske C Habermann V Fingerle B Hillenbrand S Jauris-Heipke G Lehnert I Pradel D Rössler U Schulte-Spechtel, Med Microbial Immunol 1999 188 139 144 10.1007/s004300050116 10776844
21. Genetic diversity among Borrelia strains determined by single-strand conformation polymorphism analysis of the ospC gene and its association with invasiveness. V Lagal D Postic E Ruzic-Sabljic G Baranton, J Clin Microbiol 2003 41 5059 5065 14605139 10.1128/JCM.41.11.5059-5065.2003
22. An immuno-dominant conserved region within the variable domain of VlsE1, the variable surface antigen of Borrelia burgdorferi. FT Liang AL Alvarez Y Gu JM Nowling R Ramamoorthy MT Philipp, J Immunol 1999 63 5566 5573
23. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence casettes. JR Zhang JM Hardham AG Barbour SJ Norris, Cell 1997 89 275 289 10.1016/S0092-8674(00)80206-8 9108482
24. Humoral immune response to outer surface proterin C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection. BP Fung GL McHugh JM Leong AC Steere, Infect Immun 1994 62 3213 3221 8039891
25. Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease. SJ Padula F Dias A Sampieri RB Craven RW Ryan, J Clin Microbiol 1994 32 1733 1738 7929767
26. Significant improvement of the recombinant Borrelia IgG immunoblot for serodiagnosis of early neuroborreliosis. U Schulte-Spechtel G Lehnert G Liegl V Fingerle C Heimerl B Johnson B Wilske, Int J Med Microbial 2004 293 Suppl 37 158 160 15146999
27. Peptide-based OspC enzyme-linked immunosorbent assay for the serodiagnosis of Lyme borreliosis. M Mathiesen M Christiansen K Hansen E Ösbrink M Theisen, J Clin Microbiol 1998 36 3474 3479 9817857
28. Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early Lyme borreliosis from OspA vaccination. CA Wienecke SD Lovrich SM Callister DA Jobe JA Marks RF Schell, J Clin Microbiol 2000 38 313 317 10618107
29. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. SM Engström E Shoop RC Johnson, J Clin Microbiol 1995 33 419 427 7714202
30. Evaluation of a Western blot method for the detection of Yersinia Antibodies: evidence of serological cross-reactivity between Yersinia outer membrane proteins and Borrelia burgdorferi. ML Rawlins C Gerstner HR Hill CM Litwin, Clin Diagn Lab Immunol 2005 12 1269 1274 16275939 10.1128/CDLI.12.11. 1269-1274.2005
31. A European multicenter study of immunoblotting in serodiagnosis of Lyme borreliaosis. J Robertson E Guy N Andrews B Wilske P Anda M Granström U Hauser Y Moosmann V Sambri J Schellekens G Stanek J Gray, J Clin Microbiol 2000 38 2097 2102 10834959
32. Impact of strain heterogeneity on Lyme disease serology in Europe: Comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato. U Hauser H Krahl H Peters V Fingerle B Wilske, J Clin Microbiol 1998 36 427 436 9466753